Microbot Medical Inc (NASDAQ:MBOT) shares saw an uptick in trading volume on Thursday . 4,017,894 shares traded hands during mid-day trading, an increase of 353% from the previous session’s volume of 887,524 shares.The stock last traded at $1.05 and had previously closed at $1.02.

In related news, Director Moshe Shoham sold 33,700 shares of the stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $1.50, for a total value of $50,550.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Yoseph Bornstein sold 50,000 shares of the stock in a transaction that occurred on Tuesday, September 26th. The shares were sold at an average price of $1.24, for a total transaction of $62,000.00. The disclosure for this sale can be found here. Insiders sold 508,234 shares of company stock worth $616,599 over the last 90 days. 31.83% of the stock is currently owned by company insiders.

An institutional investor recently bought a new position in Microbot Medical stock. Sabby Management LLC bought a new position in Microbot Medical Inc (NASDAQ:MBOT) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned 2.92% of Microbot Medical as of its most recent filing with the Securities & Exchange Commission. 4.72% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Microbot Medical (MBOT) Sees Large Volume Increase” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/12/14/microbot-medical-mbot-sees-large-volume-increase.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Receive News & Stock Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related stocks with our FREE daily email newsletter.